Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Postmenopausal women or men \> 60 years~* DXA T-Score at lumbar spine, total hip or femur neck \<-2,0 before the start of the bisphosphonate therapy or at baseline or at least one low trauma vertebral fracture grade 2-3 or multiple low trauma vertebral fractures independent of bone mineral densitiy~* Pretreatment with bisphosphonates for at least four years~* Risk for hip and vertebral fractures min. 30% according to DVO-guideline for osteoporosis 2009~* Signed informed consent~Exclusion Criteria:~* Other pharmacological treatment of osteoporosis during the last 48 months~* Other bone diseases~* Malabsorption syndromes~* Renal insufficiency with a calculated creatinine clearance \< 35 ml/min~* Diseases of the esophagus, delayed esophageal clearance~* UUnability to realise the intake instructions~* Hypocalcemia

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Alendronate (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).